MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker

Haibo Wang(Capital Medical University), Junqi He(Qingdao University), Yang Yang‐Hartwich(Unknown), Xuedi Cao(Capital Medical University), Ying Yang(Guizhou University), Lijie Zhang(Chinese Center For Disease Control and Prevention), Yue Wang(China Pharmaceutical University), Yumeng Yang(Huawei Technologies (China)), Duiping Feng(Shanxi Medical University), Xuan Qi(Capital Medical University), Siyu Gu, Tao Bai(Shanxi Medical University), Yibin Chen(Capital Medical University), Ran Song(University of Virginia)
Cell Death and Disease
February 16, 2025
Cited by 6


Related Papers